Alberta identifies first case of blood clot from AstraZeneca vaccine
The first Alberta case of a COVID-19 vaccine-caused blood clot has been identified, according to the province’s top doctor.
Dr. Deena Hinshaw, Alberta’s Chief Medical Officer of Health, shared Saturday morning that one case of vaccine-induced thrombotic thrombocytopenia (VITT) was discovered this week.
Linked to the AstraZeneca vaccine, it’s only the second case in Canada out of more than 700,000 doses administered of that specific vaccine.
“We have confirmed a case of the rare blood clot disorder known as VITT in Alberta. The patient is a male in his 60s who has received treatment and is recovering. To protect patient confidentiality, additional details will not be publicly released,” says Hinshaw.